New hope for tough cancers: CBX-12 drug trial begins
Disease control
Completed
This study tested a new drug called CBX-12 in 69 adults with advanced solid tumors (like ovarian, lung, or breast cancer) that had stopped responding to standard treatments. The goal was to find a safe dose and see if the drug could shrink tumors. The study was completed, but res…
Phase: PHASE1, PHASE2 • Sponsor: Cybrexa Therapeutics • Aim: Disease control
Last updated May 17, 2026 00:26 UTC